Zydotum (Ceftazidime + Sulbactam for injection) is indicated for the treatment of patients with infections caused by susceptible ESBL producing and non ESBL producing strains especially resistant P aeruginosa


  • Bone and joint infections
  • Urinary tract infections
  • Lower respiratory tract infections
  • Skin structure infections
  • Bacteremia/septicemia
  • 6.Intra-abdominal infections
  • Meningitis

Product Presentation

0.75g, 1.5g dry powder for injection

Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to VRL India, its subsidiaries or affiliates. No use of any VRL India trademark, trade name, or trade dress in this site may be made without the prior written authorization of VRL India, except to identify the product or services of the company.

Back to Top